União Europeia -
tcheco -
EMA (European Medicines Agency)
ryeqo
gedeon richter plc. - relugolix, norethisterone acetate, estradiol hemihydrate - leiomyom - hypofýzy a hypotalamické hormony a analogy - ryeqo is indicated in adult women of reproductive age for:- treatment of moderate to severe symptoms of uterine fibroids,- symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis.
União Europeia -
tcheco -
EMA (European Medicines Agency)
orgovyx
accord healthcare s.l.u. - relugolix - prostatetické novotvary - endokrinní terapie - orgovyx is indicated for the treatment of adult patients with advanced hormone-sensitive prostate cancer.
República Tcheca -
tcheco -
SUKL (Státní ústav pro kontrolu léčiv)
digoxin léČiva 0,125mg tableta
zentiva, k.s., praha array - 485 digoxin - tableta - 0,125mg - digoxin
República Tcheca -
tcheco -
SUKL (Státní ústav pro kontrolu léčiv)
digoxin léČiva 0,250mg tableta
zentiva, k.s., praha array - 485 digoxin - tableta - 0,250mg - digoxin
República Tcheca -
tcheco -
SUKL (Státní ústav pro kontrolu léčiv)
taruza 1mg tableta
zentiva, k.s., praha array - 12977 rilmenidin-fosfÁt - tableta - 1mg - rilmenidin
República Tcheca -
tcheco -
SUKL (Státní ústav pro kontrolu léčiv)
tenaxum 1mg tableta
les laboratoires servier, suresnes cedex array - 12977 rilmenidin-fosfÁt - tableta - 1mg - rilmenidin
União Europeia -
tcheco -
EMA (European Medicines Agency)
entresto
novartis europharm limited - sacubitril, valsartan - srdeční selhání - antagonisté angiotensinu ii, jiné kombinace, látky působící na renin-angiotensinový systém - paediatric heart failureentresto is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction. adult heart failureentresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.
União Europeia -
tcheco -
EMA (European Medicines Agency)
neparvis
novartis europharm limited - sacubitril, valsartan - srdeční selhání - agens působící na systém renin-angiotenzin - paediatric heart failureneparvis is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction (see section 5. adult heart failureneparvis is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction (see section 5.
União Europeia -
tcheco -
EMA (European Medicines Agency)
gavreto
roche registration gmbh - pralsetinib - karcinom, plicní jiná než malobuněčná - antineoplastická činidla - gavreto is indicated as monotherapy for the treatment of adult patients with rearranged during transfection (ret) fusion-positive advanced non-small cell lung cancer (nsclc) not previously treated with a ret inhibitor.
União Europeia -
tcheco -
EMA (European Medicines Agency)
rezolsta
janssen-cilag international n.v. - darunavir, kobicistat - hiv infekce - antivirals for systemic use, antivirals for treatment of hiv infections, combinations - rezolsta je indikován v kombinaci s dalšími antiretrovirovými léčivými přípravky pro léčbu infekce virem lidské imunodeficience 1 (hiv 1) u dospělých ve věku 18 let nebo starší. genotypové testování by se mělo řídit použití rezolsta.